Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Dynavax says U.S. FDA rejects its hepatitis B vaccine
Tuesday, November 15, 2016Dynavax Technologies Corp said on Monday the US Food and Drug Administration had rejected the marketing application for its hepatitis B vaccine HeplisavB sending the companys shares tumbling percent in premarket trading The drug developer said it r...
J&J arthritis drug goes up against Humira, with mixed results
Monday, November 14, 2016Johnson Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Incs topselling Humira in a large trial By one measure patients with moderate to severe disease who took sirukumab showed signifi...
Roche announces positive results for Actemra in phase III study
Monday, November 14, 2016Swiss drugmaker Roche said on Sunday its rheumatoid arthritis medication Actemra for giant cell arteritis showed to be superior to steroids alone in maintaining steroidfree remission in a Phase III study Results from the study showed that percent o...
Pfizer offers cut-price pneumonia shot for humanitarian crises
Saturday, November 12, 2016US pharmaceuticals giant Pfizer is to offer its pneumococcal vaccine at the lowest possible price to nongovernmental organizations seeking to protect vulnerable people from illness in humanitarian crises In what it called a major expansion of its hu...
Novo Nordisk receives positive opinion for Fiasp-drug in EU
Saturday, November 12, 2016Danish insulin maker Novo Nordisk Says receives positive opinion from the European regulatory authorities Committee for Medicinal Products for Human Use CHMP for Fiasp fastacting insulin aspart for the treatment of adults with type and type diabete...
Bristol-Myers' deepens focus on fibrosis with Nitto deal
Friday, November 11, 2016BristolMyers Squibb Co said on Thursday it agreed to pay Japans Nitto Denko Corp million up front for the right to its earlystage drug for liver fibrosis due to fatty liver disease NASH or hepatitis C Fibrotic diseases are characterized by inflamma...
Perrigo to review options for Multiple Sclerosis drug Tysabri
Friday, November 11, 2016Perrigo Co Plc reported a higherthanexpected adjusted quarterly profit and said it would review strategic options for royalty rights from sales of multiple sclerosis drug Tysabri Shares of the Dublinbased company which specializes in generic and ove...
Almac Group Announce £27 million Global Expansion
Friday, November 11, 2016Almac Group the global contract pharmaceutical development and manufacturing organisation is excited to announce ambitious plans to expand its operations in Europe and North America increasing its global headcount to reach by As part of its ongoin...
Mabion signs agreement for rights to sell Mabion CD20 drug in EU and Balkans
Thursday, November 10, 2016Mabion SA Said that it signed a longterm cooperation agreement with Mylan NVs whollyowned unit Mylan Ireland for exclusive rights to sell Mabion CD oncology drug biosimilar to MabTheraRituximab in all countries of the European Union and the Balkan co...
Bristol-Myers, Infinity Pharma to evaluate Opdivo with IPI-549 in advanced solid tumors
Thursday, November 10, 2016BristolMyers Squibb and infinity pharmaceuticals announce clinical collaboration to evaluate Opdivo nivolumab in combination with IPI in advanced solid tumors BristolMyers Squibb evaluation of IPI as a monotherapy continuing with combination portio...
